Professor Jonathan Barratt, PhD, FRCP

The Mayer Professor of Renal Medicine, Department of Cardiovascular Sciences, University of Leicester; Honorary Fellow, RWTH Aachen University; Honorary Consultant Nephrologist, John Walls Renal Unit, University Hospitals of Leicester NHS Trust; Head of the Postgraduate Specialty School of Clinical Academic Training, NHS England in the East Midlands 

Professor Jonathan Barratt’s research is focused on a bench to bedside approach to improving our understanding of the pathogenesis of IgA nephropathy a common global cause of kidney failure. He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and Convener of the International IgA Nephropathy Network. He works closely with pharmaceutical companies interested in new treatments for IgA nephropathy and is Chief Investigator for a number of international randomized controlled Phase 2 and 3 clinical trials in IgA nephropathy. He was a member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group. He is also an Editorial Board member for Kidney International and the American Society of Nephrology journals. He is a co-Chair of the UK Glomerulonephritis Clinical Study Group and is the IgA nephropathy lead for the KDIGO Clinical Practice Guidelines for Glomerular Diseases.